Guest Post: David Gibbes Miller, Rebecca Dresser, Scott Y H Kim Paper: Advance euthanasia directives: a controversial case and its ethical implications Dutch law allows advance directives to authorize euthanasia for people who can no longer make a voluntary and well-considered choice to end their lives. People make advance euthanasia directives (AEDs) with the goal of protecting themselves from […]
Category: Regulation and Regulators
More on Conscientious Objection: a Repy to a Reply
Guest post by Divine Banyubala A couple of days ago, Iain raised an interesting question about the draft Conscientious Objection (Medical Activities) Bill, and its compatibility with existing law (both civil and criminal) in respect of withdrawal of life-sustaining treatment. In an insightful reply, Mary Neal made the points that “in key areas of practice […]
Conscientious Objection: A Quick(ish) Answer
Guest post by Mary Neal, Law School, University of Strathclyde The Conscientious Objection (Medical Activities) [HL] Bill, introduced by the crossbench peer Baroness O’Loan, received its second reading in the House of Lords on Friday 26th January and successfully proceeded to the committee stage. In a post on this blog the following day, Iain posed […]
There’s a New Declaration of Geneva!
Contain your excitement if you can… The World Medical Association has issued its latest version of the Declaration of Geneva. (h/t to Mark Rapa for bringing this to my attention.) This is apparently something that it does every decade, tinkering with phrasing as it sees fit. So, then: what does it say? Well, for my […]
“Top of the Lake” may Sink as a Procedural, but Look Beneath the Surface
A couple of weeks ago, BioNews invited me to review Top of the Lake; but since it’s relevant to the kinds of things that appear in the JME, I thought I’d repost it here. There’s a moment in the final episode of this second series of Jane Campion’s Top of the Lake where Nicole Kidman’s character […]
“NOW’s interest in pharmaceutical gender equity seems to have disappeared with its funding.”
There’s a remarkable piece on the Hastings Center’s blog by Alycia Hogenmiller about a drug called Addyi. Addyi is a drug that doesn’t work to treat a condition that doesn’t exist, pushed by campaigners who are actually industry shills. Sprout Pharmaceuticals, run by Cindy and Robert Whitehead, was determined to obtain regulatory approval for flibanserin […]
Individually-Randomized Controlled Trials of Vaccines Against the Next Outbreak
Guest Post: Nir Eyal, Marc Lipsitch Paper: Vaccine testing for emerging infections: the case for individual randomisation The humbling experience of international response to Ebola taught the world a thing or two on preparing for Zika and for other emerging infections. Some of those lessons pertain to vaccine development against emerging infections. One lesson was […]
The Deadly Business of an Unregulated Global Stem Cell Market
Guest Post: The deadly business of an unregulated global stem cell industry Tereza Hendl and Tamra Lysaght In our paper, we report on the case of a 75-year old Australian woman who died in December 2013 from complications of an autologous stem cell procedure. This case was tragic and worth reporting to the medical ethics community […]
Combating Doping in Sports: More of the Same or What?
Guest Post: Bengt Kayser and Jan Tolleneer Paper: Ethics of a relaxed antidoping rule accompanied by harm-reduction measures Doping in sports continues to be prominently present in the media. Regularly ’scandals’ surface that then trigger flurries of articles, documentaries and reactions in the media. The general tone is one of moral opprobrium, dopers are considered deviant […]
Professional Codes and Diagnosis at a Distance
This is the second part of my response to Trish Greenhalgh’s post on the propriety of medics, psychiatrists in particular, offering diagnoses of Donald Trump’s mental health. In the last post, I concentrated on some of the problems associated with making such a diagnosis (or, on reflection, what might be better called a “quasi-diagnosis”). In […]